18.5 C
New York
Thursday, June 4, 2026

Tag: solid

World’s First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory...

SAN FRANCISCO and SUZHOU, China, June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...

TelkomMetra Strengthens Its Business Portfolio Restructuring Strategy, AdMedika Group Ready for Distinct Expansion under Fullerton Health

This strategic initiative aligns with Danantara Indonesia's streamlining directive to TelkomGroup in strengthening its structure and sharpening its business focus.JAKARTA, Indonesia, June 4, 2026...

StarCharge Unveils Next-Generation Energy Solutions and Strategic ANZ Partnership at SNEC 2026

SHANGHAI, June 4, 2026 /PRNewswire/ -- StarCharge, a global leader in EV charging and digital energy solutions, showcased its latest smart energy technologies and...

AIDIMM™ & AILPBGA™ Make Global Debut | Longsys Spotlights Full-Stack Edge AI Storage Solutions at COMPUTEX 2026

TAIPEI, June 4, 2026 /PRNewswire/ -- From June 2 to 5, 2026, COMPUTEX 2026 in Taipei runs under the theme "AI Together," focusing on AI...

Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032

MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.

Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026

NEWTON, Mass., June 3, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it...

Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage “Micromill” Formulation Platform, Enabling Drug Development Decision With Milligrams of API

New collaboration delivers a fully integrated formulation workflow from early solubility studies to high-throughput dissolution, stability, and in-process analytics, making drug formulation less artisanal...

/C O R R E C T I O N — Capital Community Bank/

In the news release, CCBank Launches Quill Bank to Deliver Banking Expertise to Fintechs, issued 02-Jun-2026 by Capital Community Bank over PR Newswire, we...

Zhihu Inc. Reports Unaudited First Quarter 2026 Financial Results

BEIJING, China, June 03, 2026 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter ended March 31, 2026.

SKHTU Builds US-EU Compliance System, Advancing Global Digital Finance Expansion

DENVER, June 03, 2026 (GLOBE NEWSWIRE) -- The crypto industry is undergoing a shift from “regulation chasing innovation” to “regulation driving innovation.” SKHTU Exchange recently released global compliance strategy that is a reflection of this trend. The focus is on leveraging dual US MSB and SEC licenses, while coordinating with the European MiCA regulatory framework. This approach marks the SKHTU establishment of a cross-system compliance loop within the international regulatory landscape, providing institutional safeguards for global operations.

Statkraft og Elkem inngår syvårig kraftavtale for Bjølvefossen-verket på Vestlandet

(Oslo, 3. juni 2026) Statkraft og Elkem ASA har inngått en ny langsiktig kraftavtale som sikrer konkurransedyktig og forutsigbar krafttilgang til Elkems verk på Bjølvefossen, i Kvam kommune i Vestland. Avtalen gjelder for perioden 2031–2037 og sikrer levering av totalt 1 534 GWh til verket. 

Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026

SHANGHAI and HONG KONG, June 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated...

Kelun-Biotech Presents First-in-human Study Data for Its Novel B7-H3 ADC SKB500 at ASCO 2026

CHENGDU, China, June 3, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 American Society...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSolid